Désirée van der Heijde

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Vosse D; Landewé R; van der Heijde D; van der Linden S; van Staa T-P; Geusens P
Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study.
van der Heijde D; Lie E; Kvien T K; Sieper J; Van den Bosch F; Listing J; Braun J; Landewé R;
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.
Boonen Annelies; van Berkel Monique; Cieza Alarcos; Stucki Gerold; van der Heijde Désirée
Which aspects of functioning are relevant for patients with ankylosing spondylitis: results of focus group interviews.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Désirée van der Heijde (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vosse D; Landewé R; van der Heijde D; van der Linden S; van Staa T-P; Geusens P
Ankylosing spondylitis and the risk of fracture: results from a large primary care-based nested case-control study.
Annals of the rheumatic diseases 2009;68(12):1839-42.
2009: van der Heijde D; Lie E; Kvien T K; Sieper J; Van den Bosch F; Listing J; Braun J; Landewé R;
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2009;68(12):1811-8.
2009: Boonen Annelies; van Berkel Monique; Cieza Alarcos; Stucki Gerold; van der Heijde Désirée
Which aspects of functioning are relevant for patients with ankylosing spondylitis: results of focus group interviews.
The Journal of rheumatology 2009;36(11):2501-11.
2009: Haavardsholm E A; Østergaard M; Hammer H B; Bøyesen P; Boonen A; van der Heijde D; Kvien T K
Monitoring anti-TNFalpha treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage.
Annals of the rheumatic diseases 2009;68(10):1572-9.
2009: Smolen J S; van der Heijde D M; Aletaha D; Xu S; Han J; Baker D; St Clair E W
Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing.
Annals of the rheumatic diseases 2009;68(10):1535-40.
2009: Goldbach-Mansky Raphaela; Wilson Mildred; Fleischmann Roy; Olsen Nancy; Silverfield Joel; Kempf Phillip; Kivitz Alan; Sherrer Yvonne; Pucino Frank; Csako Gyorgy; Costello Rene; Pham Tuyet Hang; Snyder Christopher; van der Heijde Désirée; Tao Xuelian; Wesley Robert; Lipsky Peter E
Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial.
Annals of internal medicine 2009;151(4):229-40, W49-51.
2009: Sharp John T; Angwin Jane; Boers Maarten; Duryea Jeff; Finckh Axel; Hall James R; Kauffman Joost A; Landewé Robert; Langs Georg; Lukas Cédric; Moens H J Bernelot; Peloschek Philipp; Strand C Vibeke; van der Heijde Désirée
Multiple computer-based methods of measuring joint space width can discriminate between treatment arms in the COBRA trial -- Update of an ongoing OMERACT project.
The Journal of rheumatology 2009;36(8):1825-8.
2009: Maksymowych Walter P; Fitzgerald Oliver; Wells George A; Gladman Dafna D; Landewé Robert; Ostergaard Mikkel; Taylor William J; Christensen Robin; Tak Paul-Peter; Boers Maarten; Syversen Silje W; Bathon Joan M; Ritchlin Christopher J; Mease Philip J; Bykerk Vivien P; Garnero Patrick; Geusens Piet; El-Gabalawy Hani; Aletaha Daniel; Inman Robert D; Kraus Virginia Byers; Kvien Tore K; van der Heijde Désirée
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
The Journal of rheumatology 2009;36(8):1792-9.
2009: Maksymowych Walter P; Landewé Robert; Tak Paul-Peter; Ritchlin Christopher J; Ostergaard Mikkel; Mease Philip J; El-Gabalawy Hani; Garnero Patrick; Gladman Dafna D; Fitzgerald Oliver; Aletaha Daniel; Bykerk Vivien P; Bathon Joan M; Syversen Silje W; Boers Maarten; Geusens Piet; Inman Robert D; Kraus Virginia B; Kvien Tore K; Taylor William J; Wells George A; van der Heijde Désirée
Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria.
The Journal of rheumatology 2009;36(8):1785-91.
2009: Syversen Silje W; Landewe Robert; van der Heijde Désirée; Bathon Joan M; Boers Maarten; Bykerk Vivian P; Fitzgerald Oliver; Gladman Dafna D; Garnero Patrick; Geusens Piet; El-Gabalawy Hani; Inman Robert D; Kraus Virginia; Kvien Tore K; Mease Philip J; Ostergaard Mikkel; Ritchlin Christopher J; Tak Paul-Peter; Taylor William J; Maksymowych Walter P
Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers.
The Journal of rheumatology 2009;36(8):1769-84.
2009: Braun Jürgen; van der Heijde Désirée; Doyle Mittie K; Han Chenglong; Deodhar Atul; Inman Robert; de Vlam Kurt; Burmester Gerd R; Van den Bosch Filip; Xu Stephen; Visvanathan Sudha; Rahman Mahboob U
Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab.
Arthritis and rheumatism 2009;61(8):1032-6.
2009: van der Woude Diane; Young Adam; Jayakumar Keeranur; Mertens Bart J; Toes René E M; van der Heijde Désirée; Huizinga Tom W J; van der Helm-van Mil Annette H M
Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts.
Arthritis and rheumatism 2009;60(8):2262-71.
2009: Boonen Annelies; van Berkel Monique; Kirchberger Inge; Cieza Alarcos; Stucki Gerald; van der Heijde Désirée
Aspects relevant for functioning in patients with ankylosing spondylitis according to the health professionals: a Delphi study with the ICF as reference.
Rheumatology (Oxford, England) 2009;48(8):997-1002.
2009: Visser K; van der Heijde D
Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature.
Annals of the rheumatic diseases 2009;68(7):1094-9.
2009: Sieper J; Rudwaleit M; Baraliakos X; Brandt J; Braun J; Burgos-Vargas R; Dougados M; Hermann K-G; Landewé R; Maksymowych W; van der Heijde D
The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis.
Annals of the rheumatic diseases 2009;68 Suppl 2():ii1-44.
2009: Dijkmans Ben; Emery Paul; Hakala Markku; Leirisalo-Repo Marjatta; Mola Emilio Martin; Paolozzi Laurence; Salvarani Carlo; Sanmarti Raimon; Sibilia Jean; Sieper Joachim; Van Den Bosch Filip; van der Heijde Désirée; van der Linden Sjef; Wajdula Joseph
Etanercept in the longterm treatment of patients with ankylosing spondylitis.
The Journal of rheumatology 2009;36(6):1256-64.
2009: Rudwaleit M; Landewé R; van der Heijde D; Listing J; Brandt J; Braun J; Burgos-Vargas R; Collantes-Estevez E; Davis J; Dijkmans B; Dougados M; Emery P; van der Horst-Bruinsma I E; Inman R; Khan M A; Leirisalo-Repo M; van der Linden S; Maksymowych W P; Mielants H; Olivieri I; Sturrock R; de Vlam K; Sieper J
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.
Annals of the rheumatic diseases 2009;68(6):770-6.
2009: Rudwaleit M; van der Heijde D; Landewé R; Listing J; Akkoc N; Brandt J; Braun J; Chou C T; Collantes-Estevez E; Dougados M; Huang F; Gu J; Khan M A; Kirazli Y; Maksymowych W P; Mielants H; Sørensen I J; Ozgocmen S; Roussou E; Valle-Oñate R; Weber U; Wei J; Sieper J
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
Annals of the rheumatic diseases 2009;68(6):777-83.
2009: Sieper J; van der Heijde D; Landewé R; Brandt J; Burgos-Vagas R; Collantes-Estevez E; Dijkmans B; Dougados M; Khan M A; Leirisalo-Repo M; van der Linden S; Maksymowych W P; Mielants H; Olivieri I; Rudwaleit M
New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).
Annals of the rheumatic diseases 2009;68(6):784-8.
2009: Smolen J; Landewé R B; Mease P; Brzezicki J; Mason D; Luijtens K; van Vollenhoven R F; Kavanaugh A; Schiff M; Burmester G R; Strand V; Vencovsky J; van der Heijde D
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial.
Annals of the rheumatic diseases 2009;68(6):797-804.
2009: van der Heijde D; Schiff M H; Sieper J; Kivitz A J; Wong R L; Kupper H; Dijkmans B A C; Mease P J; Davis J C;
Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial.
Annals of the rheumatic diseases 2009;68(6):922-9.
2009: Syversen Silje W; Goll Guro L; van der Heijde Désirée; Landewé Robert; Gaarder Per Ivar; Odegård Sigrid; Haavardsholm Espen A; Kvien Tore K
Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
The Journal of rheumatology 2009;36(2):266-72.
2009: Halvorsen E H; Haavardsholm E A; Pollmann S; Boonen A; van der Heijde D; Kvien T K; Molberg Ø
Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents.
Annals of the rheumatic diseases 2009;68(2):249-52.
2009: van der Heijde Désirée; Salonen David; Weissman Barbara N; Landewé Robert; Maksymowych Walter P; Kupper Hartmut; Ballal Shaila; Gibson Eric; Wong Robert;
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years.
Arthritis research & therapy 2009;11(4):R127.
2009: Hashimoto Jun; Garnero Patrick; van der Heijde Désirée; Miyasaka Nobuyuki; Yamamoto Kazuhiko; Kawai Shinichi; Takeuchi Tsutomu; Yoshikawa Hideki; Nishimoto Norihiro
A combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.
Modern rheumatology / the Japan Rheumatism Association 2009;19(3):273-82.
2009: Cieza A; Hilfiker R; Boonen A; van der Heijde D; Braun J; Stucki G
Towards an ICF-based clinical measure of functioning in people with ankylosing spondylitis: a methodological exploration.
Disability and rehabilitation 2009;31(7):528-37.
2008: van der Heijde Désirée; Landewé Robert; Baraliakos Xenofon; Houben Harry; van Tubergen Astrid; Williamson Paul; Xu Weichun; Baker Daniel; Goldstein Neil; Braun Jürgen;
Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis.
Arthritis and rheumatism 2008;58(10):3063-70.
2008: Karonitsch T; Aletaha D; Boers M; Bombardieri S; Combe B; Dougados M; Emery P; Felson D; Gomez-Reino J; Keystone E; Kvien T K; Martin-Mola E; Matucci-Cerinic M; Richards P; van Riel P; Siegel J; Smolen J S; Sokka T; van der Heijde D; van Vollenhoven R; Ward M; Wells G; Zink A; Landewe R
Methods of deriving EULAR/ACR recommendations on reporting disease activity in clinical trials of patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(10):1365-73.
2008: Braun Jürgen; Deodhar Atul; Dijkmans Ben; Geusens Piet; Sieper Joachim; Williamson Paul; Xu Weichun; Visvanathan Sudha; Baker Daniel; Goldstein Neil; van der Heijde Désirée;
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.
Arthritis and rheumatism 2008;59(9):1270-8.
2008: van der Heijde D; Landewé R; van Vollenhoven R; Fatenejad S; Klareskog L
Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial.
Annals of the rheumatic diseases 2008;67(9):1267-70.
2008: van der Heijde D; Pangan A L; Schiff M H; Braun J; Borofsky M; Torre J; Davis J C; Wong R L; Kupper H; Collantes E;
Adalimumab effectively reduces the signs and symptoms of active ankylosing spondylitis in patients with total spinal ankylosis.
Annals of the rheumatic diseases 2008;67(9):1218-21.
2008: Vosse D; Landewé R; Garnero P; van der Heijde D; van der Linden S; Geusens P
Association of markers of bone- and cartilage-degradation with radiological changes at baseline and after 2 years follow-up in patients with ankylosing spondylitis.
Rheumatology (Oxford, England) 2008;47(8):1219-22.
2008: Lukas Cédric; Sharp John T; Angwin Jane; Boers Maarten; Duryea Jeff; Hall James R; Kauffman Joost A; Landewé Robert; Langs Georg; Bernelot Moens Hein J; Peloschek Philipp; van der Heijde Désirée
Automated measurement of joint space width in small joints of patients with rheumatoid arthritis.
The Journal of rheumatology 2008;35(7):1288-93.
2008: Zochling Jane; Sieper Joachim; van der Heijde Désirée; Braun Jürgen;
Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy.
The Journal of rheumatology 2008;35(6):1079-82.
2008: van der Heijde D; Landewé R; Einstein S; Ory P; Vosse D; Ni L; Lin S-L; Tsuji W; Davis J C
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept.
Arthritis and rheumatism 2008;58(5):1324-31.
2008: Cohen Stanley B; Dore Robin K; Lane Nancy E; Ory Peter A; Peterfy Charles G; Sharp John T; van der Heijde Désirée; Zhou Lifen; Tsuji Wayne; Newmark Richard;
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial.
Arthritis and rheumatism 2008;58(5):1299-309.
2008: Antoni Christian E; Kavanaugh Arthur; van der Heijde Désirée; Beutler Anna; Keenan Gregory; Zhou Bei; Kirkham Bruce; Tutuncu Zuhre; Burmester Gerd R; Schneider Udo; Furst Daniel E; Molitor Jerry; Keystone Edward; Gladman Dafna D; Manger Bernhard; Wassenberg Siegfried; Weier Ralf; Wallace Daniel J; Weisman Michael H; Kalden Joachim R; Smolen Josef S
Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).
The Journal of rheumatology 2008;35(5):869-76.
2008: Dougados Maxime; Luo Michelle P; Maksymowych Walter P; Chmiel Joseph J; Chen Naijun; Wong Robert L; Davis John C; van der Heijde Désirée;
Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: data from a randomized controlled trial.
Arthritis and rheumatism 2008;59(4):553-60.
2008: van der Heijde D; Landewé R; Feldtkeller E
Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions.
Annals of the rheumatic diseases 2008;67(4):489-93.
2008: Halvorsen E H; Pollmann S; Gilboe I-M; van der Heijde D; Landewé R; Ødegård S; Kvien T K; Molberg Ø
Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity.
Annals of the rheumatic diseases 2008;67(3):414-7.
2008: Davis J C; van der Heijde D M; Braun J; Dougados M; Clegg D O; Kivitz A J; Fleischmann R M; Inman R D; Ni L; Lin S-L; Tsuji W H
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2008;67(3):346-52.
2008: Dias E M; Lukas C; Landewé R; Fatenejad S; van der Heijde D
Reliability and sensitivity to change of the Simple Erosion Narrowing Score compared with the Sharp-van der Heijde method for scoring radiographs in rheumatoid arthritis.
Annals of the rheumatic diseases 2008;67(3):375-9.
2008: van der Heijde D; Burmester G; Melo-Gomes J; Codreanu C; Mola E Martin; Pedersen R; Freundlich B; Chang D J;
The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy.
Annals of the rheumatic diseases 2008;67(2):182-8.
2008: Syversen S W; Gaarder P I; Goll G L; Ødegård S; Haavardsholm E A; Mowinckel P; van der Heijde D; Landewé R; Kvien T K
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
Annals of the rheumatic diseases 2008;67(2):212-7.
2007: van der Heijde D; Klareskog L; Landewé R; Bruyn G A W; Cantagrel A; Durez P; Herrero-Beaumont G; Molad Y; Codreanu C; Valentini G; Zahora R; Pedersen R; MacPeek D; Wajdula J; Fatenejad S
Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis.
Arthritis and rheumatism 2007;56(12):3928-39.
2007: Lie Benedicte A; Viken Marte K; Odegård Sigrid; van der Heijde Désirée; Landewé Robert; Uhlig Till; Kvien Tore K
Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
Annals of the rheumatic diseases 2007;66(12):1604-9.
2007: Landewé Robert; van der Heijde Désirée
Primer: challenges in randomized and observational studies.
Nature clinical practice. Rheumatology 2007;3(11):661-6.
2007: Vosse D; Heijckmann C; Landewé R; van der Heijde D; van der Linden S; Geusens P
Comparing morphometric X-ray absorptiometry and radiography in defining vertebral wedge fractures in patients with ankylosing spondylitis.
Rheumatology (Oxford, England) 2007;46(11):1667-71.
2007: Nishimoto Norihiro; Hashimoto Jun; Miyasaka Nobuyuki; Yamamoto Kazuhiko; Kawai Shinichi; Takeuchi Tsutomu; Murata Norikazu; van der Heijde Désirée; Kishimoto Tadamitsu
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab.
Annals of the rheumatic diseases 2007;66(9):1162-7.
2007: Davis John C; Revicki Dennis; van der Heijde Désirée M F; Rentz Anne M; Wong Robert L; Kupper Hartmut; Luo Michelle P
Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
Arthritis and rheumatism 2007;57(6):1050-7.
2007: van der Heijde D; Kavanaugh A; Gladman D D; Antoni C; Krueger G G; Guzzo C; Zhou B; Dooley L T; de Vlam K; Geusens P; Birbara C; Halter D; Beutler A
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2.
Arthritis and rheumatism 2007;56(8):2698-707.
2007: Gladman Dafna D; Inman Robert D; Cook Richard J; Maksymowych Walter P; Braun Jurgen; Davis John C; Landewé Robert B M; Mease Philip; Brandt Joachim; Vargas Ruben Burgos; Chandran Vinod; Helliwell Philip; Kavanaugh Arthur; O'Shea Finbar D; Khan Muhammad A; Pipitone Nicolo; Rahman Proton; Reveille John D; Stone Millicent A; Taylor William; Veale Douglas J; van der Heijde Desirée
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis.
The Journal of rheumatology 2007;34(8):1740-5.
2007: Gladman Dafna D; Inman Robert D; Cook Richard J; van der Heijde Desirée; Landewé Robert B M; Braun Jurgen; Davis John C; Mease Philip; Brandt Joachim; Vargas Ruben Burgos; Chandran Vinod; Helliwell Philip; Kavanaugh Arthur; O'Shea Finbar D; Khan Muhammad A; Pipitone Nicolo; Rahman Proton; Reveille John D; Stone Millicent A; Taylor William; Veale Douglas J; Maksymowych Walter P
International spondyloarthritis interobserver reliability exercise--the INSPIRE study: I. Assessment of spinal measures.
The Journal of rheumatology 2007;34(8):1733-9.
2007: Hammer Hilde Berner; Odegard Sigrid; Fagerhol Magne K; Landewé Robert; van der Heijde Désirée; Uhlig Till; Mowinckel Petter; Kvien Tore K
Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.
Annals of the rheumatic diseases 2007;66(8):1093-7.
2007: Maksymowych Walter P; Landewé Robert; Conner-Spady Barbara; Dougados Maxime; Mielants Herman; van der Tempel Hille; Poole A Robin; Wang Nandi; van der Heijde Désirée
Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.
Arthritis and rheumatism 2007;56(6):1846-53.
2007: Schett Georg; Landewé Robert; van der Heijde Désirée
Tumour necrosis factor blockers and structural remodelling in ankylosing spondylitis: what is reality and what is fiction?
Annals of the rheumatic diseases 2007;66(6):709-11.
2007: Boonen Annelies; van der Heijde Désirée; Landewé Robert; van Tubergen Astrid; Mielants Herman; Dougados Maxime; van der Linden Sjef
How do the EQ-5D, SF-6D and the well-being rating scale compare in patients with ankylosing spondylitis?
Annals of the rheumatic diseases 2007;66(6):771-7.
2007: Gladman Dafna D; Mease Philip J; Strand Vibeke; Healy Paul; Helliwell Philip S; Fitzgerald Oliver; Gottlieb Alice B; Krueger Gerald G; Nash Peter; Ritchlin Christopher T; Taylor William; Adebajo Ade; Braun Jurgen; Cauli Alberto; Carneiro Sueli; Choy Ernst; Dijkmans Ben; Espinoza Luiz; van der Heijde Desiree; Husni Elaine; Lubrano Ennio; McGonagle Dennis; Qureshi Abrar; Soriano Enrique R; Zochling Jane
Consensus on a core set of domains for psoriatic arthritis.
The Journal of rheumatology 2007;34(5):1167-70.
2007: Gladman Dafna D; Mease Philip J; Healy Paul; Helliwell Philip S; Fitzgerald Oliver; Cauli Alberto; Lubrano Ennio; Krueger Gerald G; van der Heijde Désirée; Veale Douglas J; Kavanaugh Arthur; Nash Peter; Ritchlin Christopher; Taylor William; Strand Vibeke
Outcome measures in psoriatic arthritis.
The Journal of rheumatology 2007;34(5):1159-66.
2007: Braun J; Baraliakos X; Listing J; Davis J; van der Heijde D; Haibel H; Rudwaleit M; Sieper J
Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor alpha agents.
Arthritis and rheumatism 2007;57(4):639-47.
2007: van der Heijde Désirée
Long-term effects of early treatment in patients with rheumatoid arthritis.
Nature clinical practice. Rheumatology 2007;3(5):258-9.
2007: van der Heijde Désirée; Landewé Robert; Sharp John T;
Repair in rheumatoid arthritis, current status. Report of a workshop at OMERACT 8.
The Journal of rheumatology 2007;34(4):884-8.
2007: Sharp John T; Angwin Jane; Boers Maarten; Duryea Jeff; von Ingersleben Gabriele; Hall James R; Kauffman Joost A; Landewé Robert; Langs Georg; Lukas Cédric; Maillefert Jean-Francis; Bernelot Moens Hein J; Peloschek Philipp; Strand Vibeke; van der Heijde Désirée
Computer based methods for measurement of joint space width: update of an ongoing OMERACT project.
The Journal of rheumatology 2007;34(4):874-83.
2007: van der Heijde Désirée; Landewé Robert; Hermann Kay-Geert; Rudwaleit Martin; Østergaard Mikkel; Oostveen Ans; O'Connor Phil; Maksymowych Walter P; Lambert Robert G; Lukas Cédric; Jurik Anne Grethe; Boers Maarten; Baraliakos Xenofon; Braun Jürgen;
Is there a preferred method for scoring activity of the spine by magnetic resonance imaging in ankylosing spondylitis?
The Journal of rheumatology 2007;34(4):871-3.
2007: Lukas Cédric; Braun Jürgen; van der Heijde Désirée; Hermann Kay-Geert A; Rudwaleit Martin; Østergaard Mikkel; Oostveen Ans; O'Connor Phil; Maksymowych Walter P; Lambert Robert G W; Jurik Anne Grethe; Baraliakos Xenofon; Landewé Robert;
Scoring inflammatory activity of the spine by magnetic resonance imaging in ankylosing spondylitis: a multireader experiment.
The Journal of rheumatology 2007;34(4):862-70.
2007: Maksymowych Walter P; Landewe Robert; Boers Maarten; Garnero Patrick; Geusens Piet; El-Gabalawy Hani; Heinegard Dick; Kraus Virginia B; Lohmander Stefan; Matyas John; Saxne Tore; van der Heijde Desiree
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials.
The Journal of rheumatology 2007;34(3):634-40.
2007: Keeling Stephanie O; Landewe Robert; van der Heijde Desiree; Bathon Joan; Boers Maarten; Garnero Patrick; Geusens Piet; El-Gabalawy Hani; Inman Robert D; Kraus Virginia B; Kvien Tore K; Mease Philip J; Ostergaard Mikkel; Ritchlin Chris; Syversen Silje W; Maksymowych Walter P
Testing of the preliminary OMERACT validation criteria for a biomarker to be regarded as reflecting structural damage endpoints in rheumatoid arthritis clinical trials: the example of C-reactive protein.
The Journal of rheumatology 2007;34(3):623-33.
2007: van der Heijde Désirée; Klareskog Lars
Reply to letter by Yazici and Yazici commenting on the two-year report on the trial of etanercept and methotrexate with radiographic and patient outcomes.
Arthritis and rheumatism 2007;56(3):1031-2.
2007: Maksymowych Walter P; Richardson Rhonda; Mallon Catherine; van der Heijde Désirée; Boonen Annelies
Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis.
Arthritis and rheumatism 2007;57(1):133-9.
2007: Heuft-Dorenbosch L; Landewé R; Weijers R; Houben H; van der Linden S; Jacobs P; van der Heijde D
Performance of various criteria sets in patients with inflammatory back pain of short duration; the Maastricht early spondyloarthritis clinic.
Annals of the rheumatic diseases 2007;66(1):92-8.
2007: Han Chenglong; Smolen Josef S; Kavanaugh Arthur; van der Heijde Désirée; Braun Jürgen; Westhovens René; Zhao Ning; Rahman Mahboob U; Baker Daniel; Bala Mohan
The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases.
Arthritis research & therapy 2007;9(5):R103.
2007: van der Heijde Désirée; Landewé Robert; Boonen Annelies; Einstein Steve; Herborn Gertraud; Rau Rolf; Wassenberg Siegfried; Weissman Barbara N; Winalski Carl S; Sharp John T
Expert agreement confirms that negative changes in hand and foot radiographs are a surrogate for repair in patients with rheumatoid arthritis.
Arthritis research & therapy 2007;9(4):R62.
2006: van Echteld Irene; Cieza Alarcos; Boonen Annelies; Stucki Gerold; Zochling Jane; Braun Jürgen; van der Heijde Désirée
Identification of the most common problems by patients with ankylosing spondylitis using the international classification of functioning, disability and health.
The Journal of rheumatology 2006;33(12):2475-83.
2006: van der Heijde D; Da Silva J C; Dougados M; Geher P; van der Horst-Bruinsma I; Juanola X; Olivieri I; Raeman F; Settas L; Sieper J; Szechinski J; Walker D; Boussuge M-P; Wajdula J S; Paolozzi L; Fatenejad S;
Etanercept 50 mg once weekly is as effective as 25 mg twice weekly in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2006;65(12):1572-7.
2006: Cannon Christopher P; Curtis Sean P; FitzGerald Garret A; Krum Henry; Kaur Amarjot; Bolognese James A; Reicin Alise S; Bombardier Claire; Weinblatt Michael E; van der Heijde Désirée; Erdmann Erland; Laine Loren;
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison.
Lancet 2006;368(9549):1771-81.
2006: Davis J C; Dougados M; Braun J; Sieper J; van der Heijde D; van der Linden S
Definition of disease duration in ankylosing spondylitis: reassessing the concept.
Annals of the rheumatic diseases 2006;65(11):1518-20.
2006: Landewé Robert; van der Heijde Désirée; Klareskog Lars; van Vollenhoven Ronald; Fatenejad Saeed
Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes.
Arthritis and rheumatism 2006;54(10):3119-25.
2006: van der Heijde Désirée; Han Chenglong; DeVlam Kirt; Burmester Gerd; van den Bosch Filip; Williamson Paul; Bala Mohan; Han John; Braun Jürgen
Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial.
Arthritis and rheumatism 2006;55(4):569-74.
2006: Kavanaugh A; Antoni C E; Gladman D; Wassenberg S; Zhou B; Beutler A; Keenan G; Burmester G; Furst D E; Weisman M H; Kalden J R; Smolen J; van der Heijde D
The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.
Annals of the rheumatic diseases 2006;65(8):1038-43.
2006: van der Heijde Désirée; Kivitz Alan; Schiff Michael H; Sieper Joachim; Dijkmans Ben A C; Braun Jürgen; Dougados Maxime; Reveille John D; Wong Robert L; Kupper Hartmut; Davis John C;
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2006;54(7):2136-46.
2006: Zochling Jane; Braun Jürgen; van der Heijde Désirée
Assessments in ankylosing spondylitis.
Best practice & research. Clinical rheumatology 2006;20(3):521-37.
2006: Geusens P P; Landewé R B M; Garnero P; Chen D; Dunstan C R; Lems W F; Stinissen P; van der Heijde D M F M; van der Linden S; Boers M
The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
Arthritis and rheumatism 2006;54(6):1772-7.
2006: Vosse D; van der Heijde D; Landewé R; Geusens P; Mielants H; Dougados M; van der Linden S
Determinants of hyperkyphosis in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2006;65(6):770-4.
2006: Heuft-Dorenbosch L; Landewé R; Weijers R; Wanders A; Houben H; van der Linden S; van der Heijde D
Combining information obtained from magnetic resonance imaging and conventional radiographs to detect sacroiliitis in patients with recent onset inflammatory back pain.
Annals of the rheumatic diseases 2006;65(6):804-8.
2006: Braun Jürgen; Landewé Robert; Hermann Kay-Geert A; Han John; Yan Songkai; Williamson Paul; van der Heijde Désirée;
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study.
Arthritis and rheumatism 2006;54(5):1646-52.
2006: Landewé R; van der Heijde D; van der Linden S; Boers M
Twenty-eight-joint counts invalidate the DAS28 remission definition owing to the omission of the lower extremity joints: a comparison with the original DAS remission.
Annals of the rheumatic diseases 2006;65(5):637-41.
2006: van der Heijde Désirée; Klareskog Lars; Rodriguez-Valverde Vicente; Codreanu Catalin; Bolosiu Horatiu; Melo-Gomes Jose; Tornero-Molina Jesus; Wajdula Joseph; Pedersen Ronald; Fatenejad Saeed;
Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial.
Arthritis and rheumatism 2006;54(4):1063-74.
2006: Smolen Josef S; Han Chenglong; van der Heijde Désirée; Emery Paul; Bathon Joan M; Keystone Edward; Kalden Joachim R; Schiff Michael; Bala Mohan; Baker Daniel; Han John; Maini Ravinder N; St Clair E William
Infliximab treatment maintains employability in patients with early rheumatoid arthritis.
Arthritis and rheumatism 2006;54(3):716-22.
2006: Smolen Josef S; Van Der Heijde Désirée M F M; St Clair E William; Emery Paul; Bathon Joan M; Keystone Edward; Maini Ravinder N; Kalden Joachim R; Schiff Michael; Baker Daniel; Han Chenglong; Han John; Bala Mohan;
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
Arthritis and rheumatism 2006;54(3):702-10.
2006: Braun J; Davis J; Dougados M; Sieper J; van der Linden S; van der Heijde D;
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2006;65(3):316-20.
2006: van der Heijde D; Klareskog L; Singh A; Tornero J; Melo-Gomes J; Codreanu C; Pedersen R; Freundlich B; Fatenejad S
Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
Annals of the rheumatic diseases 2006;65(3):328-34.
2006: Bathon Joan M; Fleischmann Roy M; Van der Heijde Désirée; Tesser John R; Peloso Paul M; Chon Yun; White Barbara
Safety and efficacy of etanercept treatment in elderly subjects with rheumatoid arthritis.
The Journal of rheumatology 2006;33(2):234-43.
2006: Boonen A; van der Heijde D; Severens J L; Boendermaker A; Landewé R; Braun J; Brandt J; Sieper J; van der Linden Sj
Markov model into the cost-utility over five years of etanercept and infliximab compared with usual care in patients with active ankylosing spondylitis.
Annals of the rheumatic diseases 2006;65(2):201-8.
2006: Ødegård Sigrid; Landewé Robert; van der Heijde Désirée; Kvien Tore K; Mowinckel Petter; Uhlig Till
Association of early radiographic damage with impaired physical function in rheumatoid arthritis: a ten-year, longitudinal observational study in 238 patients.
Arthritis and rheumatism 2006;54(1):68-75.
2006: Landewé R B M; Geusens P; van der Heijde D M F M; Boers M; van der Linden S J; Garnero P
Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.
Annals of the rheumatic diseases 2006;65(1):40-4.
2006: Landewé Robert; van der Heijde Désirée
The validity of a rheumatoid arthritis medical records-based index of severity compared with the DAS28.
Arthritis research & therapy 2006;8(3):107.
2006: Heuft-Dorenbosch Liesbeth; Weijers René; Landewé Robert; van der Linden Sjef; van der Heijde Désirée
Magnetic resonance imaging changes of sacroiliac joints in patients with recent-onset inflammatory back pain: inter-reader reliability and prevalence of abnormalities.
Arthritis research & therapy 2006;8(1):R11.
2005: Sharp John T; van der Heijde Desiree; Angwin Jane; Duryea Jeff; Moens Heins J Bernelot; Jacobs Johannes W G; Maillefert Jean-Francis; Strand C Vibeke;
Measurement of joint space width and erosion size.
The Journal of rheumatology 2005;32(12):2456-61.
2005: Boonen Annelies; van der Heijde Désirée
Conventional x-ray in early arthritis.
Rheumatic diseases clinics of North America 2005;31(4):681-98.
2005: Svensson Björn; Boonen Annelies; Albertsson Kristina; van der Heijde Désirée; Keller Catharina; Hafström Ingiäld
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
Arthritis and rheumatism 2005;52(11):3360-70.
2005: Landewé R; van der Heijde D
Presentation and analysis of radiographic data in clinical trials and observational studies.
Annals of the rheumatic diseases 2005;64 Suppl 4():iv48-51.
2005: Boonen A; Severens J L; van Tubergen A; Landewé R; Bonsel G; van der Heijde D; van der Linden Sj
Willingness of patients with ankylosing spondylitis to pay for inpatient treatment is influenced by the treatment environment and expectations of improvement.
Annals of the rheumatic diseases 2005;64(11):1650-2.
2005: van der Heijde D; Klareskog L; Boers M; Landewé R; Codreanu C; Bolosiu H D; Pedersen R; Fatenejad S;
Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results.
Annals of the rheumatic diseases 2005;64(11):1582-7.
2005: Sigl T; Cieza A; van der Heijde D; Stucki G
ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis.
Annals of the rheumatic diseases 2005;64(11):1576-81.
2005: Davis J C; van der Heijde D M; Braun J; Dougados M; Cush J; Clegg D; Inman R D; Kivitz A; Zhou L; Solinger A; Tsuji W
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
Annals of the rheumatic diseases 2005;64(11):1557-62.
2005: Gossec L; van der Heijde D; Melian A; Krupa D A; James M K; Cavanaugh P F; Reicin A S; Dougados M
Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis.
Annals of the rheumatic diseases 2005;64(11):1563-7.
2005: Hermann Kay-Geert A; Landewé Robert B M; Braun Jürgen; van der Heijde Désirée M F M
Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
The Journal of rheumatology 2005;32(10):2056-60.
2005: Landewé Robert B M; Hermann Kay-Geert A; van der Heijde Désirée M F M; Baraliakos Xenophon; Jurik Anne-Grethe; Lambert Robert G; Østergaard Mikkel; Rudwaleit Martin; Salonen David C; Braun Jürgen
Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
The Journal of rheumatology 2005;32(10):2050-5.
2005: van der Heijde Désirée; Landewé Robert
Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT.
The Journal of rheumatology 2005;32(10):2048-9.
2005: van der Heijde Désirée M F M; Landewé Robert B M; Hermann Kay-Geert A; Jurik Anne-Grethe; Maksymowych Walter P; Rudwaleit Martin; O'Connor Philip J; Braun Jürgen
Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
The Journal of rheumatology 2005;32(10):2042-7.
2005: Landewé Robert; van der Heijde Désirée
Radiographic progression in rheumatoid arthritis.
Clinical and experimental rheumatology 2005;23(5 Suppl 39):S63-8.
2005: Davis John C; Van der Heijde Désirée M F M; Dougados Maxime; Braun Jurgen; Cush John J; Clegg Daniel O; Inman Robert D; de Vries Todd; Tsuji Wayne H
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
The Journal of rheumatology 2005;32(9):1751-4.
2005: Davis John C; van der Heijde Désirée; Dougados Maxime; Woolley J Michael
Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy.
Arthritis and rheumatism 2005;53(4):494-501.
2005: Baraliakos X; Hermann K-G A; Landewé R; Listing J; Golder W; Brandt J; Rudwaleit M; Bollow M; Sieper J; van der Heijde D; Braun J
Assessment of acute spinal inflammation in patients with ankylosing spondylitis by magnetic resonance imaging: a comparison between contrast enhanced T1 and short tau inversion recovery (STIR) sequences.
Annals of the rheumatic diseases 2005;64(8):1141-4.
2005: van der Heijde Désirée; Landewé Robert; van der Linden Sjef
How should treatment effect on spinal radiographic progression in patients with ankylosing spondylitis be measured?
Arthritis and rheumatism 2005;52(7):1979-85.
2005: Wanders A; Landewé R; Dougados M; Mielants H; van der Linden Sj; van der Heijde D
Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?
Annals of the rheumatic diseases 2005;64(7):988-94.
2005: van der Heijde Désirée; Landewé Robert
Imaging in spondylitis.
Current opinion in rheumatology 2005;17(4):413-7.
2005: Spoorenberg A; van Tubergen A; Landewé R; Dougados M; van der Linden S; Mielants H; van de Tempel H; van der Heijde D
Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives.
Rheumatology (Oxford, England) 2005;44(6):789-95.
2005: Baraliakos X; Landewé R; Hermann K-G; Listing J; Golder W; Brandt J; Rudwaleit M; Bollow M; Sieper J; van der Heijde D; Braun J
Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging.
Annals of the rheumatic diseases 2005;64(5):730-4.
2005: Boonen Annelies; van der Heijde Désirée
Review of the costs of illness of ankylosing spondylitis and methodologic notes.
Expert review of pharmacoeconomics & outcomes research 2005;5(2):163-81.
2005: van der Heijde Désirée; Baraf Herbert S B; Ramos-Remus Cesar; Calin Andrei; Weaver Arthur L; Schiff Michael; James Margaret; Markind Jan E; Reicin Alise S; Melian Agustin; Dougados Maxime
Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
Arthritis and rheumatism 2005;52(4):1205-15.
2005: Smolen J S; Han C; Bala M; Maini R N; Kalden J R; van der Heijde D; Breedveld F C; Furst D E; Lipsky P E;
Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Arthritis and rheumatism 2005;52(4):1020-30.
2005: van der Heijde D; Sharp J; Wassenberg S; Gladman D D
Psoriatic arthritis imaging: a review of scoring methods.
Annals of the rheumatic diseases 2005;64 Suppl 2():ii61-4.
2005: van der Heijde D; Braun J; Landewé R; Davis J; Sieper J; van der Linden S; Dougados M
ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?
Annals of the rheumatic diseases 2005;64 Suppl 2():ii108-9.
2005: Boonen A; van den Heuvel R; van Tubergen A; Goossens M; Severens J L; van der Heijde D; van der Linden S
Large differences in cost of illness and wellbeing between patients with fibromyalgia, chronic low back pain, or ankylosing spondylitis.
Annals of the rheumatic diseases 2005;64(3):396-402.
2005: van der Heijde Désirée; Dougados Maxime; Davis John; Weisman Michael H; Maksymowych Walter; Braun Jürgen; Hallegua David S; Bruckel Jane;
ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis.
Arthritis and rheumatism 2005;52(2):386-94.
2005: van der Heijde Désirée; Dijkmans Ben; Geusens Piet; Sieper Joachim; DeWoody Kimberly; Williamson Paul; Braun Jürgen;
Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT).
Arthritis and rheumatism 2005;52(2):582-91.
2005: Bruynesteyn K; Boers M; Kostense P; van der Linden S; van der Heijde D
Deciding on progression of joint damage in paired films of individual patients: smallest detectable difference or change.
Annals of the rheumatic diseases 2005;64(2):179-82.
2005: van der Heijde Désirée; Landewé Robert; Klareskog Lars; Rodríguez-Valverde Vicente; Settas Lucas; Pedersen Ronald; Fatenejad Saeed
Presentation and analysis of data on radiographic outcome in clinical trials: experience from the TEMPO study.
Arthritis and rheumatism 2005;52(1):49-60.
2005: Schurgers Leon J; Teunissen Kirsten J F; Knapen Marjo H J; Geusens Piet; van der Heijde Desiree; Kwaijtaal Martijn; van Diest Rob; Ketteler Markus; Vermeer Cees
Characteristics and performance of an immunosorbent assay for human matrix Gla-protein.
Clinica chimica acta; international journal of clinical chemistry 2005;351(1-2):131-8.
2005: Breedveld F C; Han C; Bala M; van der Heijde D; Baker D; Kavanaugh A F; Maini R N; Lipsky P E
Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis.
Annals of the rheumatic diseases 2005;64(1):52-5.
2005: Schuwirth L; Gorter S; Van der Heijde D; Rethans J J; Brauer J; Houben H; Van der Linden S; Van der Vleuten C; Scherpbier A
The role of a computerised case-based testing procedure in practice performance assessment.
Advances in health sciences education : theory and practice 2005;10(2):145-55.
2004: van der Heijde Désirée
Quantification of radiological damage in inflammatory arthritis: rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Best practice & research. Clinical rheumatology 2004;18(6):847-60.
2004: Wanders A; Landewé R; Spoorenberg A; de Vlam K; Mielants H; Dougados M; van der Linden S; van der Heijde D
Scoring of radiographic progression in randomised clinical trials in ankylosing spondylitis: a preference for paired reading order.
Annals of the rheumatic diseases 2004;63(12):1601-4.
2004: St Clair E William; van der Heijde Désirée M F M; Smolen Josef S; Maini Ravinder N; Bathon Joan M; Emery Paul; Keystone Edward; Schiff Michael; Kalden Joachim R; Wang Ben; Dewoody Kimberly; Weiss Roberta; Baker Daniel;
Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.
Arthritis and rheumatism 2004;50(11):3432-43.
2004: van der Heijde Désirée
Intensive management reduced disease activity in rheumatoid arthritis.
ACP journal club 2004;141(3):70.
2004: Bruynesteyn K; Wanders A; Landewé R; van der Heijde D
How the type of risk reduction influences required sample sizes in randomised clinical trials.
Annals of the rheumatic diseases 2004;63(11):1368-71.
2004: Brandt J; Listing J; Sieper J; Rudwaleit M; van der Heijde D; Braun J
Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis.
Annals of the rheumatic diseases 2004;63(11):1438-44.
2004: Bruynesteyn K; Landewé R; van der Linden Sj; van der Heijde D
Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months' follow up.
Annals of the rheumatic diseases 2004;63(11):1413-8.
2004: Boonen A; Van Der Heijde D; Landewé R; Chorus A; Van Lankveld W; Miedema H; Van Der Tempel H; Van Der Linden S
Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?
Annals of the rheumatic diseases 2004;63(10):1264-8.
2004: Heuft-Dorenbosch Liesbeth; Vosse Debby; Landewé Robert; Spoorenberg Anneke; Dougados Maxime; Mielants Herman; van der Tempel Hille; van der Linden Sjef; van der Heijde Désirée
Measurement of spinal mobility in ankylosing spondylitis: comparison of occiput-to-wall and tragus-to-wall distance.
The Journal of rheumatology 2004;31(9):1779-84.
2004: Braun J; Baraliakos X; Golder W; Hermann K-G; Listing J; Brandt J; Rudwaleit M; Zuehlsdorf S; Bollow M; Sieper J; van der Heijde D
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems.
Annals of the rheumatic diseases 2004;63(9):1046-55.
2004: Wanders Astrid J B; Landewé Robert B M; Spoorenberg Anneke; Dougados Maxime; van der Linden Sjef; Mielants Herman; van der Tempel Hille; van der Heijde Désirée M F M
What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter.
Arthritis and rheumatism 2004;50(8):2622-32.
2004: Welsing Paco M J; Landewé Robert B M; van Riel Piet L C M; Boers Maarten; van Gestel Anke M; van der Linden Sjef; Swinkels Hilde L; van der Heijde Désirée M F M
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis.
Arthritis and rheumatism 2004;50(7):2082-93.
2004: Bruynesteyn Karin; Van Der Linden Sjef; Landewé Robert; Gubler Feikje; Weijers René; Van Der Heijde Désirée
Progression of rheumatoid arthritis on plain radiographs judged differently by expert radiologists and rheumatologists.
The Journal of rheumatology 2004;31(6):1088-94.
2004: Sharp John T; Wolfe Frederick; Lassere Marissa; Boers Maarten; Van Der Heijde Désirée; Larsen Arvi; Paulus Harold; Rau Rolf; Strand Vibeke
Variability of precision in scoring radiographic abnormalities in rheumatoid arthritis by experienced readers.
The Journal of rheumatology 2004;31(6):1062-72.
2004: van der Heijde D; Kalden J; Scott D; Smolen J; Strand V
Long term evaluation of radiographic disease progression in a subset of patients with rheumatoid arthritis treated with leflunomide beyond 2 years.
Annals of the rheumatic diseases 2004;63(6):737-9.
2004: Bruynesteyn Karin; van der Heijde Désirée; Boers Maarten; van der Linden Sjef; Lassere Marissa; van der Vleuten Cees
The Sharp/van der Heijde method out-performed the Larsen/Scott method on the individual patient level in assessing radiographs in early rheumatoid arthritis.
Journal of clinical epidemiology 2004;57(5):502-12.
2004: van der Heijde D M F M
Overview of radiologic efficacy of new treatments.
Rheumatic diseases clinics of North America 2004;30(2):285-93, vi.
2004: Landewé Robert; Geusens Piet; Boers Maarten; van der Heijde Désirée; Lems Willem; te Koppele Johan; van der Linden Sjef; Garnero Patrick
Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
Arthritis and rheumatism 2004;50(5):1390-9.
2004: Pham T; van der Heijde D; Altman R D; Anderson J J; Bellamy N; Hochberg M; Simon L; Strand V; Woodworth T; Dougados M
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2004;12(5):389-99.
2004: Rudwaleit M; van der Heijde D; Khan M A; Braun J; Sieper J
How to diagnose axial spondyloarthritis early.
Annals of the rheumatic diseases 2004;63(5):535-43.
2004: Landewé R; Rump B; van der Heijde D; van der Linden S
Which patients with ankylosing spondylitis should be treated with tumour necrosis factor inhibiting therapy? A survey among Dutch rheumatologists.
Annals of the rheumatic diseases 2004;63(5):530-4.
2004: Maini R N; Breedveld F C; Kalden J R; Smolen J S; Furst D; Weisman M H; St Clair E W; Keenan G F; van der Heijde D; Marsters P A; Lipsky P E;
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.
Arthritis and rheumatism 2004;50(4):1051-65.
2004: Heuft-Dorenbosch Liesbeth; van Tubergen Astrid; Spoorenberg Anneke; Landewé Robert; Dougados Maxime; Mielants Herman; van der Tempel Hille; van der Heijde Désirée
The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index.
Arthritis and rheumatism 2004;51(2):154-9.
2004: van der Heijde Désirée
New directions in classification and outcome assessment in ankylosing spondylitis.
Current rheumatology reports 2004;6(2):98-101.
2004: van der Heijde Désirée M F M
Assessment of radiographs in longitudinal observational studies.
The Journal of rheumatology. Supplement 2004;69():46-7.
2004: Landewé Robert; van der Heijde Désirée
Radiographic progression depicted by probability plots: presenting data with optimal use of individual values.
Arthritis and rheumatism 2004;50(3):699-706.
2004: Klareskog Lars; van der Heijde Désirée; de Jager Julien P; Gough Andrew; Kalden Joachim; Malaise Michel; Martín Mola Emilio; Pavelka Karel; Sany Jacques; Settas Lucas; Wajdula Joseph; Pedersen Ronald; Fatenejad Saeed; Sanda Marie;
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
Lancet 2004;363(9410):675-81.
2004: Wanders Astrid J B; Gorman Jennifer D; Davis John C; Landewe Robert B M; van der Heijde Désirée M F M
Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis.
Arthritis and rheumatism 2004;51(1):1-8.
2004: Spoorenberg Anneke; de Vlam Kurt; van der Linden Sjef; Dougados Maxime; Mielants Herman; van de Tempel Hille; van der Heijde Désirée
Radiological scoring methods in ankylosing spondylitis. Reliability and change over 1 and 2 years.
The Journal of rheumatology 2004;31(1):125-32.
2004: Udrea Gabriela; Ciobanu Cristina; Mihai Carina; Stoica V; Suteanu St; van der Heijde Désirée; van der Linden S
Evaluation of a Romanian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) in patients with spondylarthropathies.
Romanian journal of internal medicine = Revue roumaine de médecine interne 2004;42(1):199-209.
2003: de Klerk Erik; van der Heijde Désirée; Landewé Robert; van der Tempel Hille; van der Linden Sjef
The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study.
The Journal of rheumatology 2003;30(11):2469-75.
2003: Davis John C; Van Der Heijde Désirée; Braun Jurgen; Dougados Maxime; Cush John; Clegg Daniel O; Kivitz Alan; Fleischmann Roy; Inman Robert; Tsuji Wayne;
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
Arthritis and rheumatism 2003;48(11):3230-6.
2003: van der Heijde D; Landewé R
Imaging: do erosions heal?
Annals of the rheumatic diseases 2003;62 Suppl 2():ii10-2.
2003: van der Heijde Désirée
Impact of imaging in established rheumatoid arthritis.
Best practice & research. Clinical rheumatology 2003;17(5):783-90.
2003: Braun J; Pham T; Sieper J; Davis J; van der Linden Sj; Dougados M; van der Heijde D;
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2003;62(9):817-24.
2003: Landewé Robert B M; van der Heijde Désirée M F M
Early rheumatoid arthritis: toward tailor-made therapy.
Current rheumatology reports 2003;5(4):287-93.
2003: Miceli-Richard Corinne; van der Heijde Désirée; Dougados Maxime
Spondyloarthropathy for practicing rheumatologists: diagnosis, indication for disease-controlling antirheumatic therapy, and evaluation of the response.
Rheumatic diseases clinics of North America 2003;29(3):449-62.
2003: Boonen A; van der Heijde D; Landewé R; Guillemin F; Spoorenberg A; Schouten H; Rutten-van Mölken M; Dougados M; Mielants H; de Vlam K; van der Tempel H; van der Linden Sj
Costs of ankylosing spondylitis in three European countries: the patient's perspective.
Annals of the rheumatic diseases 2003;62(8):741-7.
2003: Boonen A; van der Heijde D; Landewé R; Guillemin F; Rutten-van Mölken M; Dougados M; Mielants H; de Vlam K; van der Tempel H; Boesen S; Spoorenberg A; Schouten H; van der Linden Sj
Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.
Annals of the rheumatic diseases 2003;62(8):732-40.
2003: Pham Thao; Van Der Heijde Désirée; Lassere Marissa; Altman Roy D; Anderson Jennifer J; Bellamy Nicholas; Hochberg Marc; Simon Lee; Strand Vibeke; Woodworth Thasia; Dougados Maxime;
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria.
The Journal of rheumatology 2003;30(7):1648-54.
2003: Braun Juergen; van der Heijde Désirée
Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides.
Expert opinion on investigational drugs 2003;12(7):1097-109.
2003: Landewé Robert B M; van der Heijde Désirée M F M
Principles of assessment from a clinical perspective.
Best practice & research. Clinical rheumatology 2003;17(3):365-79.
2003: van Tubergen A; Heuft-Dorenbosch L; Schulpen G; Landewé R; Wijers R; van der Heijde D; van Engelshoven J; van der Linden Sj
Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality?
Annals of the rheumatic diseases 2003;62(6):519-25.
2003: Van Der Heijde Désirée; Sharp John T; Rau Rolf; Strand Vibeke;
OMERACT workshop: repair of structural damage in rheumatoid arthritis.
The Journal of rheumatology 2003;30(5):1108-9.
2003: Sharp John T; Van Der Heijde Désirée; Boers Maarten; Boonen Annelies; Bruynesteyn Karin; Emery Paul; Genant Harry K; Herborn Gertraud; Jurik Anne; Lassere Marissa; McQueen Fiona; Østergaard Mikkel; Peterfy Charles; Rau Rolf; Strand Vibeke; Wassenberg Siegfried; Weissman Barbara;
Repair of erosions in rheumatoid arthritis does occur. Results from 2 studies by the OMERACT Subcommittee on Healing of Erosions.
The Journal of rheumatology 2003;30(5):1102-7.
2003: Braun J; Baraliakos X; Golder W; Brandt J; Rudwaleit M; Listing J; Bollow M; Sieper J; Van Der Heijde D
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system.
Arthritis and rheumatism 2003;48(4):1126-36.
2003: Schulpen G J C; Vierhout W P M; van der Heijde D M; Landewé R B; van der Linden S; Winkens R A G
[The value of joint general practitioner and rheumatologist consultations in primary care patients]
Nederlands tijdschrift voor geneeskunde 2003;147(10):447-50.
2003: Feldtkeller Ernst; Khan Muhammad Asim; van der Heijde Désirée; van der Linden Sjef; Braun Jürgen
Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis.
Rheumatology international 2003;23(2):61-6.
2003: van Tubergen A; van der Heijde D; Anderson J; Landewé R; Dougados M; Braun J; Bellamy N; Udrea G; van der Linden Sj
Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel.
Annals of the rheumatic diseases 2003;62(3):215-21.
2003: Schulpen G J C; Vierhout W P M; van der Heijde D M; Landewé R B; Winkens R A G; van der Linden S
Joint consultation of general practitioner and rheumatologist: does it matter?
Annals of the rheumatic diseases 2003;62(2):159-61.
2003: van Tubergen A; Landewé R; Heuft-Dorenbosch L; Spoorenberg A; van der Heijde D; van der Tempel H; van der Linden S
Assessment of disability with the World Health Organisation Disability Assessment Schedule II in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2003;62(2):140-5.
2003: Heuft-Dorenbosch L; Spoorenberg A; van Tubergen A; Landewé R; van ver Tempel H; Mielants H; Dougados M; van der Heijde D
Assessment of enthesitis in ankylosing spondylitis.
Annals of the rheumatic diseases 2003;62(2):127-32.
2003: Landewé R B M; Boers M; van der Heijde D M F M
How to interpret radiological progression in randomized clinical trials?
Rheumatology (Oxford, England) 2003;42(1):2-5.
2003: de Klerk Erik; van der Heijde Désirée; Landewé Robert; van der Tempel Hille; Urquhart John; van der Linden Sjef
Patient compliance in rheumatoid arthritis, polymyalgia rheumatica, and gout.
The Journal of rheumatology 2003;30(1):44-54.
2002: Auleley Guy-Robert; Benbouazza Karima; Spoorenberg Anneke; Collantes Eduardo; Hajjaj-Hassouni Najia; van der Heijde Desirée; Dougados Maxime
Evaluation of the smallest detectable difference in outcome or process variables in ankylosing spondylitis.
Arthritis and rheumatism 2002;47(6):582-7.
2002: van der Heijde D; Braun J; McGonagle D; Siegel J
Treatment trials in ankylosing spondylitis: current and future considerations.
Annals of the rheumatic diseases 2002;61 Suppl 3():iii24-32.
2002: Braun J; Golder W; Bollow M; Sieper J; van der Heijde D
Imaging and scoring in ankylosing spondylitis.
Clinical and experimental rheumatology 2002;20(6 Suppl 28):S178-84.
2002: Garnero Patrick; Landewé Robert; Boers Maarten; Verhoeven Arco; Van Der Linden Sjef; Christgau Stephan; Van Der Heijde Désirée; Boonen Annelies; Geusens Piet
Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.
Arthritis and rheumatism 2002;46(11):2847-56.
2002: Bruynesteyn Karin; Van Der Heijde Désirée; Boers Maarten; Saudan Ariane; Peloso Paul; Paulus Harold; Houben Harry; Griffiths Bridget; Edmonds John; Bresnihan Barry; Boonen Annelies; Van Der Linden Sjef
Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence.
The Journal of rheumatology 2002;29(11):2306-12.
2002: Bruynesteyn Karin; Van Der Heijde Désirée; Boers Maarten; Verhoeven Arco; Boonen Annelies; Van Der Linden Sjef;
Contribution of progression of erosive damage in previously eroded joints in early rheumatoid arthritis trials: COBRA trial as an example.
Arthritis and rheumatism 2002;47(5):532-6.
2002: Van Tubergen Astrid; Boonen Annelies; Landewé Robert; Rutten-Van Mölken Maureen; Van Der Heijde Désirée; Hidding Alita; Van Der Linden Sjef
Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial.
Arthritis and rheumatism 2002;47(5):459-67.
2002: Dougados Maxime; van der Heijde Désirée
Ankylosing spondylitis: how should the disease be assessed?
Best practice & research. Clinical rheumatology 2002;16(4):605-18.
2002: Gorter Simone; Rethans Jan-Joost; van der Heijde Désirée; Scherpbier Albert; Houben Harry; van der Vleuten Cees; van der Linden Sjef
Reproducibility of clinical performance assessment in practice using incognito standardized patients.
Medical education 2002;36(9):827-32.
2002: Spoorenberg A; van der Heijde D; Dougados M; de Vlam K; Mielants H; van de Tempel H; van der Linden S
Reliability of self assessed joint counts in ankylosing spondylitis.
Annals of the rheumatic diseases 2002;61(9):799-803.
2002: Gorter Simone; Scherpbier Albert; Brauer Jolanda; Rethans Jan-Joost; van der Heijde Désirée; Houben Harry; van der Vleuten Cees; van der Linden Sjef
Doctor-patient interaction: standardized patients' reflections from inside the rheumatological office.
The Journal of rheumatology 2002;29(7):1496-500.
2002: Boonen A; Chorus A; Landewé R; van der Heijde D; Miedema H; van der Tempel H; van der Linden Sj
Manual jobs increase the risk of patients with ankylosing spondylitis withdrawing from the labour force, also when adjusted for job related withdrawal in the general population.
Annals of the rheumatic diseases 2002;61(7):658.
2002: Van Tubergen Astrid; Debats Iris; Ryser Liliane; Londoño John; Burgos-Vargas Ruben; Cardiel Mario H; Landewé Robert; Stucki Gerold; Van Der Heijde Désirée
Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires.
Arthritis and rheumatism 2002;47(3):242-8.
2002: Boonen A; van der Heijde D; Landewé R; Spoorenberg A; Schouten H; Rutten-van Mölken M; Guillemin F; Dougados M; Mielants H; de Vlam K; van der Tempel H; van der Linden Sj
Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.
Annals of the rheumatic diseases 2002;61(5):429-37.
2002: van der Heijde Désirée; Simon Lee; Smolen Josef; Strand Vibeke; Sharp John; Boers Maarten; Breedveld Ferdinand; Weisman Michael; Weinblatt Michael; Rau Rolf; Lipsky Peter
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion.
Arthritis and rheumatism 2002;47(2):215-8.
2002: Bruynesteyn Karin; van der Heijde Désirée; Boers Maarten; Saudan Ariane; Peloso Paul; Paulus Harold; Houben Harry; Griffiths Bridget; Edmonds John; Bresnihan Barry; Boonen Annelies; van der Linden Sjef
Determination of the minimal clinically important difference in rheumatoid arthritis joint damage of the Sharp/van der Heijde and Larsen/Scott scoring methods by clinical experts and comparison with the smallest detectable difference.
Arthritis and rheumatism 2002;46(4):913-20.
2002: van Santen Marijke; Bolwijn Paulien; Verstappen Frans; Bakker Carla; Hidding Alita; Houben Harry; van der Heijde Desiree; Landewé Robert; van der Linden Sjef
A randomized clinical trial comparing fitness and biofeedback training versus basic treatment in patients with fibromyalgia.
The Journal of rheumatology 2002;29(3):575-81.
2002: Gorter S; van der Heijde D M F M; van der Linden S; Houben H; Rethans J J; Scherpbier A J J A; van der Vleuten C P M
Psoriatic arthritis: performance of rheumatologists in daily practice.
Annals of the rheumatic diseases 2002;61(3):219-24.
2002: van Tubergen Astrid; Coenen Jolanda; Landewé Robert; Spoorenberg Anneke; Chorus Astrid; Boonen Annelies; van der Linden Sjef; van der Heijde Désirée
Assessment of fatigue in patients with ankylosing spondylitis: a psychometric analysis.
Arthritis and rheumatism 2002;47(1):8-16.
2002: Landewé Robert B M; Boers Maarten; Verhoeven Arco C; Westhovens Rene; van de Laar Mart A F J; Markusse Harry M; van Denderen J Christiaan; Westedt Marie Louise; Peeters Andre J; Dijkmans Ben A C; Jacobs Piet; Boonen Annelies; van der Heijde Désirée M F M; van der Linden Sjef
COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.
Arthritis and rheumatism 2002;46(2):347-56.
2002: Sieper Joachim; Rudwaleit Martin; Braun Jürgen; van der Heijde Désirée
Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays.
Arthritis and rheumatism 2002;46(2):319-27.
2002: Boers Maarten; van der Heijde Désirée M F M
Prevention or retardation of joint damage in rheumatoid arthritis: issues of definition, evaluation and interpretation of plain radiographs.
Drugs 2002;62(12):1717-24.
2002: van der Heijde Désirée
Structural damage in rheumatoid arthritis as visualized through radiographs.
Arthritis research 2002;4 Suppl 2():S29-33.
2001: Swinkels H L; Laan R F; van 't Hof M A; van der Heijde D M; de Vries N; van Riel P L
Modified sharp method: factors influencing reproducibility and variability.
Seminars in arthritis and rheumatism 2001;31(3):176-90.
2001: van der Heijde D
Radiographic progression in rheumatoid arthritis: does it reflect outcome? Does it reflect treatment?
Annals of the rheumatic diseases 2001;60 Suppl 3():iii47-50.
2001: Boonen A; Chorus A; Miedema H; van der Heijde D; Landewé R; Schouten H; van der Tempel H; van der Linden S
Withdrawal from labour force due to work disability in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2001;60(11):1033-9.
2001: van Tubergen A; Landewé R; van der Heijde D; Hidding A; Wolter N; Asscher M; Falkenbach A; Genth E; Thè H G; van der Linden S
Combined spa-exercise therapy is effective in patients with ankylosing spondylitis: a randomized controlled trial.
Arthritis and rheumatism 2001;45(5):430-8.
2001: Geusens P; Vosse D; van der Heijde D; Vanhoof J; van Tubergen A; Raus J; van der Linden S
High prevalence of thoracic vertebral deformities and discal wedging in ankylosing spondylitis patients with hyperkyphosis.
The Journal of rheumatology 2001;28(8):1856-61.
2001: Boonen A; de Vet H; van der Heijde D; van der Linden S
Work status and its determinants among patients with ankylosing spondylitis. A systematic literature review.
The Journal of rheumatology 2001;28(5):1056-62.
2001: van der Heijde D; Lassere M; Edmonds J; Kirwan J; Strand V; Boers M
Minimal clinically important difference in plain films in RA: group discussions, conclusions, and recommendations. OMERACT Imaging Task Force.
The Journal of rheumatology 2001;28(4):914-7.
2001: Lassere M N; van der Heijde D; Johnson K; Bruynesteyn K; Molenaar E; Boonen A; Verhoeven A; Emery P; Boers M
Robustness and generalizability of smallest detectable difference in radiological progression.
The Journal of rheumatology 2001;28(4):911-3.
2001: Bruynesteyn K; van der Heijde D; Boers M; Lassere M; Boonen A; Edmonds J; Houben H; Paulus H; Peloso P; Saudan A; van der Linden S
Minimal clinically important difference in radiological progression of joint damage over 1 year in rheumatoid arthritis: preliminary results of a validation study with clinical experts.
The Journal of rheumatology 2001;28(4):904-10.
2001: Lassere M N; van der Heijde D; Johnson K R; Boers M; Edmonds J
Reliability of measures of disease activity and disease damage in rheumatoid arthritis: implications for smallest detectable difference, minimal clinically important difference, and analysis of treatment effects in randomized controlled trials.
The Journal of rheumatology 2001;28(4):892-903.
2001: Lassere M N; van der Heijde D; Johnson K R
Foundations of the minimal clinically important difference for imaging.
The Journal of rheumatology 2001;28(4):890-1.
2001: Boonen A; van der Heijde D; van der Linden S
Muhammad Asim Khan. Portrait of a rheumatologist as a great artist.
The Journal of rheumatology 2001;28(4):843-4.
2001: Boonen A; Chorus A; Miedema H; van der Heijde D; van der Tempel H; van der Linden S
Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients.
Annals of the rheumatic diseases 2001;60(4):353-8.
2001: Gorter S; van der Linden S; Brauer J; van der Heijde D; Houben H; Rethans J J; Scherpbier A; van der Vleuten C; Boonen A; Dinant H; Thè H G; Griep E; van der Horst-Bruinsma I; Linssen A; van Santen-Hoeufft M; van der Tempel H; Westgeest T
Rhemulatologists' performance in dailiy practice.
Arthritis and rheumatism 2001;45(1):16-27.
2001: Dougados M; Béhier J M; Jolchine I; Calin A; van der Heijde D; Olivieri I; Zeidler H; Herman H
Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug.
Arthritis and rheumatism 2001;44(1):180-5.
2000: Gorter S; Rethans J J; Scherpbier A; van der Heijde D; Houben H; van der Vleuten C; van der Linden S
Developing case-specific checklists for standardized-patient-based assessments in internal medicine: A review of the literature.
Academic medicine : journal of the Association of American Medical Colleges 2000;75(11):1130-7.
2000: Dougados M; Leclaire P; van der Heijde D; Bloch D A; Bellamy N; Altman R D
Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative.
Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society 2000;8(6):395-403.
2000: Proudman S M; Conaghan P G; Richardson C; Griffiths B; Green M J; McGonagle D; Wakefield R J; Reece R J; Miles S; Adebajo A; Gough A; Helliwell P; Martin M; Huston G; Pease C; Veale D J; Isaacs J; van der Heijde D M; Emery P
Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone.
Arthritis and rheumatism 2000;43(8):1809-19.
2000: van der Linden S; van der Heijde D
Clinical aspects, outcome assessment, and management of ankylosing spondylitis and postenteric reactive arthritis.
Current opinion in rheumatology 2000;12(4):263-8.
2000: Molenaar E; van der Heijde D; Boers M
Update on outcome assessment in rheumatic disorders.
Current opinion in rheumatology 2000;12(2):91-8.
2000: van der Heijde D M; van Riel P L; Nuver-Zwart I H; van de Putte L B
Alternative methods for analysis of radiographic damage in a randomized, double blind, parallel group clinical trial comparing hydroxychloroquine and sulfasalazine.
The Journal of rheumatology 2000;27(2):535-8; discussion 538-9.
2000: van der Heijde D
How to read radiographs according to the Sharp/van der Heijde method.
The Journal of rheumatology 2000;27(1):261-3.
1999: de Klerk E; van der Heijde D; van der Tempel H; van der Linden S
Development of a questionnaire to investigate patient compliance with antirheumatic drug therapy.
The Journal of rheumatology 1999;26(12):2635-41.
1999: van Der Heijde D; Boonen A; Boers M; Kostense P; van Der Linden S
Reading radiographs in chronological order, in pairs or as single films has important implications for the discriminative power of rheumatoid arthritis clinical trials.
Rheumatology (Oxford, England) 1999;38(12):1213-20.
1999: van der Heijde D; Dankert T; Nieman F; Rau R; Boers M
Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis.
Rheumatology (Oxford, England) 1999;38(10):941-7.
1999: van der Heijde D; van der Linden S; Dougados M; Bellamy N; Russell A S; Edmonds J
Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments.
The Journal of rheumatology 1999;26(4):1003-5.
1999: Spoorenberg A; de Vlam K; van der Heijde D; de Klerk E; Dougados M; Mielants H; van der Tempel H; Boers M; van der Linden S
Radiological scoring methods in ankylosing spondylitis: reliability and sensitivity to change over one year.
The Journal of rheumatology 1999;26(4):997-1002.
1999: van der Heijde D; Spoorenberg A
Plain radiographs as an outcome measure in ankylosing spondylitis.
The Journal of rheumatology 1999;26(4):985-7.
1999: Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.
The Journal of rheumatology 1999;26(4):980-4.
1999: Spoorenberg A; van der Heijde D; de Klerk E; Dougados M; de Vlam K; Mielants H; van der Tempel H; van der Linden S
A comparative study of the usefulness of the Bath Ankylosing Spondylitis Functional Index and the Dougados Functional Index in the assessment of ankylosing spondylitis.
The Journal of rheumatology 1999;26(4):961-5.
1999: van der Heijde D; Calin A; Dougados M; Khan M A; van der Linden S; Bellamy N
Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.
The Journal of rheumatology 1999;26(4):951-4.
1999: van der Heijde D; van der Linden S; Bellamy N; Calin A; Dougados M; Khan M A
Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV.
The Journal of rheumatology 1999;26(4):945-7.
1999: Molenaar E T; Boers M; van der Heijde D M; Alarcón G; Bresnihan B; Cardiel M; Edmonds J; Felson D; Furst D E; Kirwan J; Lassere M; Paulus H; Rau R; van Riel P L; Scott D; Simon L; Strand V
Imaging in rheumatoid arthritis: results of group discussions.
The Journal of rheumatology 1999;26(3):749-51.
1999: Molenaar E T; Edmonds J; Boers M; van der Heijde D M; Lassere M
A practical exercise in reading RA radiographs by the larsen and sharp methods.
The Journal of rheumatology 1999;26(3):746-8.
1999: van der Heijde D
How to read radiographs according to the Sharp/van der Heijde method.
The Journal of rheumatology 1999;26(3):743-5.
1999: Lassere M; Boers M; van der Heijde D; Boonen A; Edmonds J; Saudan A; Verhoeven A C
Smallest detectable difference in radiological progression.
The Journal of rheumatology 1999;26(3):731-9.
1999: van der Heijde D; Boers M; Lassere M
Methodological issues in radiographic scoring methods in rheumatoid arthritis.
The Journal of rheumatology 1999;26(3):726-30.
1998: van der Heijde D M; van der Linden S
Measures of outcome in ankylosing spondylitis and other spondyloarthritides.
Baillière's clinical rheumatology 1998;12(4):683-93.
1998: van der Linden S; van der Heijde D
Ankylosing spondylitis. Clinical features.
Rheumatic diseases clinics of North America 1998;24(4):663-76, vii.
1997: van der Heijde D; Bellamy N; Calin A; Dougados M; Khan M A; van der Linden S
Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.
The Journal of rheumatology 1997;24(11):2225-9.
1997: Boers M; Verhoeven A C; Markusse H M; van de Laar M A; Westhovens R; van Denderen J C; van Zeben D; Dijkmans B A; Peeters A J; Jacobs P; van den Brink H R; Schouten H J; van der Heijde D M; Boonen A; van der Linden S
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
Lancet 1997;350(9074):309-18.
1997: de Klerk E; van der Linden S; van der Heijde D; Urquhart J
Facilitated analysis of data on drug regimen compliance.
Statistics in medicine 1997;16(14):1653-64.
1997: Russel M G; Pastoor C J; Brandon S; Rijken J; Engels L G; van der Heijde D M; Stockbrügger R W
Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease.
Digestion 1997;58(3):282-8.
1996: van der Heijde D M
Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability.
Baillière's clinical rheumatology 1996;10(3):435-53.
1996: van der Linden S; van der Heijde D M
Clinical and epidemiologic aspects of ankylosing spondylitis and spondyloarthropathies.
Current opinion in rheumatology 1996;8(4):269-74.
1995: van der Heijde D M
Joint erosions and patients with early rheumatoid arthritis.
British journal of rheumatology 1995;34 Suppl 2():74-8.
1995: van Riel P L; van der Heijde D M; Nuver-Zwart I H; van de Putte L B
Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.
The Journal of rheumatology 1995;22(9):1797-9.
1995: van der Heijde D M; van Leeuwen M A; van Riel P L; van de Putte L B
Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification).
The Journal of rheumatology 1995;22(9):1792-6.
1995: van der Linden S; van der Heijde D M
Ankylosing spondylitis and other B27 related spondylarthropathies.
Baillière's clinical rheumatology 1995;9(2):355-73.
1994: van Leeuwen M A; van der Heijde D M; van Rijswijk M H; Houtman P M; van Riel P L; van de Putte L B; Limburg P C
Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.
The Journal of rheumatology 1994;21(3):425-9.
1993: van Leeuwen M A; van Rijswijk M H; van der Heijde D M; Te Meerman G J; van Riel P L; Houtman P M; van De Putte L B; Limburg P C
The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease.
British journal of rheumatology 1993;32 Suppl 3():9-13.
1993: van der Heijde D M; van 't Hof M; van Riel P L; van de Putte L B
Development of a disease activity score based on judgment in clinical practice by rheumatologists.
The Journal of rheumatology 1993;20(3):579-81.
1993: van der Heijde D M; van 't Hof M; van Riel P L; van de Putte L B
Validity of single variables and indices to measure disease activity in rheumatoid arthritis.
The Journal of rheumatology 1993;20(3):538-41.
1992: van der Heijde D M; van Riel P L; van Leeuwen M A; van 't Hof M A; van Rijswijk M H; van de Putte L B
Prognostic factors for radiographic damage and physical disability in early rheumatoid arthritis. A prospective follow-up study of 147 patients.
British journal of rheumatology 1992;31(8):519-25.
1992: van der Heijde D M; van't Hof M A; van Riel P L; van Leeuwen M A; van Rijswijk M H; van de Putte L B
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.
Annals of the rheumatic diseases 1992;51(2):177-81.
1992: van der Heijde D M; van Leeuwen M A; van Riel P L; Koster A M; van 't Hof M A; van Rijswijk M H; van de Putte L B
Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis.
Arthritis and rheumatism 1992;35(1):26-34.
1991: van der Heijde D M; van Riel P L; van Leeuwen M A; van 't Hof M A; van Rijswijk M H; van de Putte L B
Older versus younger onset rheumatoid arthritis: results at onset and after 2 years of a prospective followup study of early rheumatoid arthritis.
The Journal of rheumatology 1991;18(9):1285-9.
1990: van der Heijde D M; van 't Hof M A; van Riel P L; Theunisse L A; Lubberts E W; van Leeuwen M A; van Rijswijk M H; van de Putte L B
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score.
Annals of the rheumatic diseases 1990;49(11):916-20.
1990: van der Heijde D M; van Riel P L; Nuver-Zwart I H; van de Putte L B
Sulphasalazine versus hydroxychloroquine in rheumatoid arthritis: 3-year follow-up.
Lancet 1990;335(8688):539.
1990: van der Heijde D M; van Riel P L; van de Putte L B
Sensitivity of a Dutch Health Assessment Questionnaire in a trial comparing hydroxychloroquine vs. sulphasalazine.
Scandinavian journal of rheumatology 1990;19(6):407-12.
1989: van der Heijde D M; van Riel P L; Nuver-Zwart I H; Gribnau F W; vad de Putte L B
Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.
Lancet 1989;1(8646):1036-8.
1988: van der Heijde D M; van Riel P L; van Rijswijk M H; van de Putte L B
Influence of prognostic features on the final outcome in rheumatoid arthritis: a review of the literature.
Seminars in arthritis and rheumatism 1988;17(4):284-92.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Désirée van der Heijde

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Anatomy

Occupations

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Désirée van der Heijde (preview)

All Publications